161
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Orphan drug approvals in Europe since 2001: an analysis by indication

, MBA PhD
Pages 131-139 | Published online: 08 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Peter Norman. (2015) Orphan drug approvals of 2014: Europe and the United States. Expert Opinion on Orphan Drugs 3:4, pages 445-455.
Read now
Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now
Peter Norman. (2013) Repurposing as a strategy for orphan drug development, evidence from European approvals. Expert Opinion on Orphan Drugs 1:6, pages 473-480.
Read now

Articles from other publishers (1)

Hirokuni Mizoguchi, Takayuki Yamanaka & Shingo Kano. (2016) Research and drug development activities in rare diseases: differences between Japan and Europe regarding influence of prevalence. Drug Discovery Today 21:10, pages 1681-1689.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.